|
Report Date : |
06.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
SD BIOSENSOR, INC. |
|
|
|
|
Registered Office : |
4th Fl., C-dong, Digital Empire Bldg. 980-3, Yeongtong 2-dong, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea 443-702 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
27.12.2010 |
|
|
|
|
Com. Reg. No.: |
135-86-13315 |
|
|
|
|
Legal Form : |
Co., Ltd by Shares |
|
|
|
|
Line of Business : |
Manufacture of Other Medical and Surgical Equipment and
Orthopedic Appliances |
|
|
|
|
No. of Employees : |
61 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Slow |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
South Korea |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SOUTH KOREA - ECONOMIC OVERVIEW
South Korea over the past four decades has demonstrated incredible growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion dollar club of world economies, and currently is among the world's 20 largest economies. Initially, a system of close government and business ties, including directed credit and import restrictions, made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea''s development model including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in 1999-2000. Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. With the global economic downturn in late 2008, South Korean GDP growth slowed to 0.3% in 2009. In the third quarter of 2009, the economy began to recover, in large part due to export growth, low interest rates, and an expansionary fiscal policy, and growth was 3.6% in 2011. In 2011, the US-South Korea Free Trade Agreement was ratified by both governments and is projected to go into effect in early 2012. The South Korean economy''s long term challenges include a rapidly aging population, inflexible labor market, and heavy reliance on exports - which comprise half of GDP.
Source
: CIA
|
Company
Name |
SD BIOSENSOR, INC. (Korean Company
Name : “에스디바이오센서(주)”) |
|
Registered Address |
980-3, Yeongtong 2-dong, Yeongtong-gu,
Suwon-si, Gyeonggi-do, Korea |
|
Building |
4th Fl., C-dong, Digital Empire Bldg. |
|
Zip Code |
443-702 |
|
Tel |
+82-31-300-0400 |
|
Fax |
+82-31-300-0499 |
|
E-mail |
sales@sdbiosensor.com |
|
Website |
www.sdbiosensor.com |
|
Trading Address |
4~5 Fl., C-dong, Digital Empire Bldg.,
980-3, Yeongtong 2-dong, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea |
|
Tel |
+82-31-300-0400 |
|
Fax |
+82-31-300-0499 |
|
Other Address |
2FL., 238, Digital Empire Bldg., 980-3,
Yeongtong-dong, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea |
|
Other Address |
28B-1L, Dongtan-myeon, Hwaseong-si,
Gyeonggi-do, Korea |
|
Type |
Export/Import |
|
Industry |
Manufacture of Other Medical and Surgical Equipment and Orthopedic
Appliances n.e.c. |
|
Main Business |
Blood Glucose Meters |
|
Established (mm/dd/yyyy) |
12/27/2010 |
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Glucose analyzers(41115830) |
|
Sell |
Glucose monitors or meters(41116201) |
|
Sell |
Cholesterol monitors or meters(41116202) |
|
Name |
Lee Hyo-Keun |
|
Address |
Suite 644-904, 965-2, Yeongtong-dong, Yeongtong-gu, Suwon-si,
Gyeonggi-do, Korea |
|
Date of Birth |
10/12/1963 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital (KRW) |
437,143,000 |
||||||||||||
|
Employees |
61 |
||||||||||||
|
Formation |
Co., Ltd by Shares |
||||||||||||
|
Bank Details |
Industrial Bank of Korea |
||||||||||||
|
Corporate Registered No. |
135811-0191121 |
||||||||||||
|
Business Registered No. |
135-86-13315 |
||||||||||||
|
Permit & Licenses |
Int’l Trade No.: 31008929 |
||||||||||||
|
Shareholder Position |
(*)The list is based as of 12/31/2012 |
||||||||||||
|
Company History |
12/27/2010 Incorporated as the present name
after split off from STANDARD DIAGNOSTICS, INC(130111-0050615) 03/03/2012 Increased capital to 360,000,000
KRW from 437,143,000 KRW |
||||||||||||
|
|
|
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Date |
|
President & CEO |
Mr. |
Lee Hyo-Keun |
Male |
Korean |
06/01/2011 |
|
Director |
Mr. |
Cho Young-Sik |
Male |
Korean |
12/27/2010 |
|
Director |
Mr. |
Yoon Seok-Doo |
Male |
Korean |
12/27/2010 |
|
Outside Director |
Mr. |
Zhu Wei |
Male |
Chinese |
02/29/2012 |
|
Auditor |
Mr. |
Kim Young-Min |
Male |
Korean |
12/27/2010 |
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
15,764,583,878 |
20,344,602,695 |
115,674,224 |
|
|
2010 |
- |
15,617,370,341 |
-62,911,893 |
|
Authorized Capital(KRW) |
1,000,000,000 |
|
Paid-Up Capital(KRW) |
437,143,000 |
|
Total Issued Shares |
874,286 |
Balance
Sheet
|
|||
|
Unit : Korean Won |
As of 12/31/2011 |
As of 12/31/2010 |
As of 12/31/2009 |
|
Total Assets |
20,344,602,695 |
15,617,370,341 |
|
|
Current Assets |
10,497,832,237 |
6,543,841,287 |
|
|
-Quick Assets |
5,627,781,982 |
4,723,648,073 |
|
|
-Inventories |
4,870,050,255 |
1,820,193,214 |
|
|
Fixed Assets |
9,846,770,458 |
9,073,529,054 |
|
|
-Investment |
9,562,048,374 |
9,048,952,082 |
|
|
-Tangibles |
52,377,282 |
12,056,972 |
|
|
-Intangibles |
232,344,802 |
12,520,000 |
|
|
Total Liabilities |
6,306,080,008 |
1,694,154,678 |
|
|
Current Liabilities |
6,185,202,440 |
1,625,201,610 |
|
|
Fixed Liabilities |
120,877,568 |
68,953,068 |
|
|
Capital Stock |
360,000,000 |
360,000,000 |
|
|
Capital Surplus |
13,625,760,356 |
13,626,127,556 |
|
|
Profit Surplus |
52,762,331 |
-62,911,893 |
|
|
Capital Adjustment |
|
|
|
|
Total Equity |
14,038,522,687 |
13,923,215,663 |
|
|
Liab. & Shareholder’s Equity |
20,344,602,695 |
15,617,370,341 |
|
|
Current Liabilities |
6,185,202,440 |
1,625,201,610 |
|
|
Short-Term Borrowings |
2,000,000,000 |
- |
|
|
Trade Payables |
3,410,785,016 |
1,385,697,825 |
|
|
Account Payables |
350,459,056 |
203,645,406 |
|
|
Accrued Expenses |
53,765,830 |
35,858,379 |
|
|
Advance Receipts |
136,186,612 |
- |
|
|
Withholdings |
32,591,380 |
- |
|
|
Accrued Income Tax |
201,414,546 |
- |
|
|
Fixed Liabilities |
120,877,568 |
68,953,068 |
|
|
Provision for Severance & Retirement |
120,877,568 |
- |
|
|
Deferred Income Tax Credit |
- |
68,953,068 |
|
Income
Statement
|
|||
|
Unit : Korean Won |
As of 12/31/2011 |
As of 12/31/2010 |
As of 12/31/2009 |
|
Sales |
15,764,583,878 |
- |
|
|
Cost of Sold Goods |
11,336,617,331 |
- |
|
|
Gross Profit |
4,427,966,547 |
- |
|
|
Selling & Admin. Expenses |
4,343,312,042 |
79,831,013 |
|
|
Operating Income |
84,654,505 |
-79,831,013 |
|
|
Non-Operating Income |
281,919,002 |
286,528 |
|
|
Non-Operating Expenses |
287,299,349 |
26,579,748 |
|
|
Income Before Taxes |
79,274,158 |
-106,124,233 |
|
|
Income Taxes Expenses |
-36,400,066 |
-43,212,340 |
|
|
Net Income |
115,674,224 |
-62,911,893 |
|
Cash
Flows
|
|||
|
Unit : Korean Won |
As of 12/31/2011 |
As of 12/31/2010 |
As of 12/31/2009 |
|
Cash Flows from Operating |
-855,840,272 |
-19,920,790 |
|
|
-Net Income |
115,674,224 |
-62,911,893 |
|
|
-Exp. without Cash Outflow |
959,954,695 |
50,761,547 |
|
|
-Revenue without Cash Inflows |
-37,519,120 |
-1,481,082 |
|
|
-Changes in Asset/ & Liability |
-1,893,950,071 |
-6,289,362 |
|
|
Cash Flows from Investing |
-1,351,543,703 |
- |
|
|
-Cash Inflow from Investing |
54,600,000 |
- |
|
|
-Cash Outflows for Investing |
-1,406,143,703 |
- |
|
|
Cash Flows from Financing |
1,999,632,800 |
- |
|
|
-Cash Inflows from Financing |
2,000,000,000 |
- |
|
|
-Cash Outflows from Financing |
-367,200 |
- |
|
|
Increase/Decrease in Cash |
207,751,175 |
19,920,790 |
|
|
Cash at the Beginning of Year |
980,079,210 |
1,000,000,000 |
|
|
Cash at the End of Year |
772,328,035 |
980,079,210 |
|
|
Main Products & Services |
Blood Glucose Meters |
|
Suppliers |
STANDARD DIAGNOSTICS, INC(130111-0050615) |
|
Competitors |
SOOIL DEVELOPMENT CO., LTD. 111-1, HEUKSEOK-DONG, DONGJAK-GU, SEOUL,
KOREA TEL:+82-2-814-0041 FAX:+82-2-823-0735 UNITMA CO., LTD. 3RD FL., CHEONGMYEONG BLDG., 224-8,
JAMSILBON-DONG, SONGPA-GU, SEOUL, KOREA TEL:+82-2-420-0070 FAX:+82-2-420-9797 MEDIYES CO., LTD. 5FH FL., YEJI BLDG., 278-33, SEONGSAN
1-DONG, MAPO-GU, SEOUL, KOREA TEL:+82-2-326-1681 FAX:+82-2-326-1689 |
(Subsidiaries,
Joint-Venture & Affiliates)
|
Affiliates |
SD BIO STANDARD DIAGNOSTICS PVT LTD. STANDARD DIAGNOSTICS, INC(130111-0050615) |
|
Cooperative Enterprise |
-Insured company HANWHA GENERAL INSURANCE CO., LTD.(110111-0006456) |
(Activity & Markets)
Not Available.
No.
--
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.65 |
|
|
1 |
Rs.82.66 |
|
Euro |
1 |
Rs.71.21 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.